Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy and safety trial of AJG533 with long term treatment in patients with chronic constipation

Next Previous
Trial Profile

Efficacy and safety trial of AJG533 with long term treatment in patients with chronic constipation

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 28 Apr 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Elobixibat (Primary)
  • Indications Constipation
  • Focus Adverse reactions; Registrational
  • Sponsors Ajinomoto Pharma; Albireo AB; EA Pharma

    • Most Recent Events

    • 09 Jul 2018 According to an Eisai Co Ltd media release, data from this trial has been published in The Lancet Gastroenterology & Hepatology, and was also presented at the Digestive Disease Week (DDW) 2018.
    • 05 Jun 2018 Results determining the safety and efficacy of elobixibat for the treatment of chronic constipation from two trials (JapicCTI-153061 and JapicCTI-153062) presented at the Digestive Disease Week 2018
    • 30 May 2017 Status changed from active, no longer recruiting to completed.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top